Targeted in chronic and undertreated pathologies of high prevalence.
New generation of dietary foods for more effective treatments.
innovation and licensing +
We already have more than 80 patents and licenses of international marketing. All our nutraceuticals products have log category of Food for Special Medical Purposes.
We are a Biomedical Company specialized in Medical Nutrition,
founded in 2007 in Barcelona (Spain), we develop activities of research, development, innovation, marketing and licensing-out of new nutraceuticals and functional foods.
Our great value is the investigation and we firmly believe in the alliance between “Company-University”. We have two R&D&i centers.
From our production plant we offer our nutraceuticals products in different gastro-resistant formats (tablets, pellets, micropellets, capsules, microcapsules and nanocapsules), facilitating the adaptation to the current regulations of each market and their marketing on an international scale.
We also develop In Vitro molecular diagnostic kits.
specialists in the DAO deficit
DAO deficiency is an alteration in the metabolism of food histamine that occurs when there is little activity of the enzyme diamine oxidase (DAO). The DAO is the main enzyme in the metabolism of exogenous histamine and begins its functional activity in the intestine.
When exists a disproportion between the histamine swallowed or released by the cells that store it in the body, and the ability to metabolize it, there is the accumulation of histamine in plasma and the appearance of adverse effects.
A deficit in the metabolic activity of diamine oxidase can be due to genetic, pharmacological and pathological factors.
main symptoms in DAO DEFICIT
Migraine, fibromyalgia, irritable bowel syndrome (IBS) and the attention deficit-hyperactivity disorder (ADHD) are the symptoms with higher prevalences in the world population caused by DAO deficiency.
Actuality about deficit of dao
News in media and press releases
Clinical evidence and scientific publications